Specifically, the subset of dendritic cells that are CD8α+ appears to be important for mediating this effect (Fuertes et al., 2011), as these cells perform antigen cross presentation and priming of CD8+ T-cells, which are responsible for the cytotoxic anti-tumor immune response (Woo et al., 2014). The gene discussed is CD8A; the disease is neoplasm.